Yuhan Corp Preferred (000105) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Yuhan Corp Preferred (000105) has a cash flow conversion efficiency ratio of 0.016x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩37.15 Billion ≈ $25.18 Million USD) by net assets (₩2.34 Trillion ≈ $1.59 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Yuhan Corp Preferred to measure how much of total assets are equity-financed.
Yuhan Corp Preferred - Cash Flow Conversion Efficiency Trend (2014–2025)
This chart illustrates how Yuhan Corp Preferred's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Yuhan Corp Preferred earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Yuhan Corp Preferred Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Yuhan Corp Preferred ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shree Rama Newsprint Limited
NSE:RAMANEWS
|
0.111x |
|
ENERGY&MACHINERY KOREA Co.Ltd
KQ:095190
|
0.194x |
|
SelfWealth Limited
AU:SWF
|
0.093x |
|
Woori SPAC 3
KQ:198440
|
0.050x |
|
Kaya Limited
NSE:KAYA
|
-0.131x |
|
Mentice AB
ST:MNTC
|
0.214x |
|
Aimflex Bhd
KLSE:0209
|
0.004x |
|
Information and Communication Networks Public Company Limited
BK:ICN
|
0.114x |
Annual Cash Flow Conversion Efficiency for Yuhan Corp Preferred (2014–2025)
The table below shows the annual cash flow conversion efficiency of Yuhan Corp Preferred from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Yuhan Corp Preferred.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩2.36 Trillion ≈ $1.60 Billion |
₩106.23 Billion ≈ $71.99 Million |
0.045x | +77.12% |
| 2024-12-31 | ₩2.15 Trillion ≈ $1.46 Billion |
₩54.60 Billion ≈ $37.00 Million |
0.025x | -60.58% |
| 2023-12-31 | ₩1.98 Trillion ≈ $1.34 Billion |
₩127.75 Billion ≈ $86.58 Million |
0.064x | +29.92% |
| 2022-12-31 | ₩2.01 Trillion ≈ $1.36 Billion |
₩99.53 Billion ≈ $67.45 Million |
0.050x | -3.07% |
| 2021-12-31 | ₩1.94 Trillion ≈ $1.31 Billion |
₩99.00 Billion ≈ $67.09 Million |
0.051x | +227.54% |
| 2020-12-31 | ₩1.85 Trillion ≈ $1.25 Billion |
₩28.83 Billion ≈ $19.54 Million |
0.016x | -60.96% |
| 2019-12-31 | ₩1.65 Trillion ≈ $1.12 Billion |
₩65.99 Billion ≈ $44.72 Million |
0.040x | -29.32% |
| 2018-12-31 | ₩1.65 Trillion ≈ $1.12 Billion |
₩93.45 Billion ≈ $63.33 Million |
0.057x | -27.94% |
| 2017-12-31 | ₩1.61 Trillion ≈ $1.09 Billion |
₩126.13 Billion ≈ $85.47 Million |
0.079x | +58.48% |
| 2016-12-31 | ₩1.50 Trillion ≈ $1.01 Billion |
₩74.14 Billion ≈ $50.25 Million |
0.050x | -46.47% |
| 2015-12-31 | ₩1.36 Trillion ≈ $924.32 Million |
₩126.23 Billion ≈ $85.55 Million |
0.093x | +25.11% |
| 2014-12-31 | ₩1.28 Trillion ≈ $864.64 Million |
₩94.39 Billion ≈ $63.96 Million |
0.074x | -- |
About Yuhan Corp Preferred
Yuhan Corporation operates as a pharmaceutical company in South Korea and internationally. It offers manufacturing services, such as custom manufacturing; process research and development of active pharmaceutical products (APIs) and intermediates; kilo and pilot-scale production of APIs and intermediates; commercial production of APIs and intermediates; production of chemical specialties; and ana… Read more